Immunoadjuvant capacity of flagellin and mannosamine-coated poly(anhydride) nanoparticles in oral vaccination

Vaccine

Volumn 27, Issue 35, 2009, Pages 4784-4790

  Salman, Hesham H ^a   Irache, Juan M ^a   Gamazo, Carlos ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

Author keywords

Flagellin; Mannosamine; Nanoparticle; Oral immunization

Indexed keywords

FLAGELLIN; GANTREZ COPOLYMER; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G1; IMMUNOLOGICAL ADJUVANT; MANNOSAMINE; NANOPARTICLE; OVALBUMIN; SALMONELLOSIS VACCINE; SECRETORY IMMUNOGLOBULIN;

ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ARTICLE; CONTROLLED STUDY; DRUG ANTIGENICITY; IMMUNOGENICITY; MOUSE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; SALMONELLA ENTERITIDIS; SCANNING ELECTRON MICROSCOPY; SINGLE DRUG DOSE; VACCINE PRODUCTION;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, ORAL; ANIMALS; FLAGELLIN; HEXOSAMINES; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INJECTIONS, SUBCUTANEOUS; INTESTINAL MUCOSA; MICE; MICE, INBRED BALB C; NANOPARTICLES; OVALBUMIN;

EID: 67650224017     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.05.091     Document Type: Article

References (59)

1. Plotkin S.A. Vaccines: past, present and future. Nat Med 11 4 Suppl. (2005) S5-S11
2. Kaufmann S.H. The contribution of immunology to the rational design of novel antibacterial vaccines. Nat Rev Microbiol 5 7 (2007) 491-504
3. Stertman L., Strindelius L., and Sjoholm I. Starch microparticles as an adjuvant in immunisation: effect of route of administration on the immune response in mice. Vaccine 22 21-22 (2004) 2863-2872
4. Rydell N., and Sjoholm I. Oral vaccination against diphtheria using polyacryl starch microparticles as adjuvant. Vaccine 22 9-10 (2004) 1265-1274
5. Kim S.Y., Doh H.J., Jang M.H., Ha Y.J., Chung S.I., and Park H.J. Oral immunization with Helicobacter pylori-loaded poly(d,l-lactide-co-glycolide) nanoparticles. Helicobacter 4 1 (1999) 33-39
6. Michael J.G. The role of digestive enzymes in orally induced immune tolerance. Immunol Invest 18 9-10 (1989) 1049-1054
7. Mowat A.M. Anatomical basis of tolerance and immunity to intestinal antigens. Nat Rev Immunol 3 4 (2003) 331-341
8. Hori M., Onishi H., and Machida Y. Evaluation of Eudragit-coated chitosan microparticles as an oral immune delivery system. Int J Pharm 297 1-2 (2005) 223-234
9. Coppi G., Iannuccelli V., Sala N., and Bondi M. Alginate microparticles for Polymyxin B Peyer's patches uptake: microparticles for antibiotic oral administration. J Microencapsul 21 8 (2004) 829-839
10. Van Der Lubben I.M., Konings F.A., Borchard G., Verhoef J.C., and Junginger H.E. In vivo uptake of chitosan microparticles by murine Peyer's patches: visualization studies using confocal laser scanning microscopy and immunohistochemistry. J Drug Target 9 1 (2001) 39-47
11. McClean S., Prosser E., Meehan E., O'Malley D., Clarke N., Ramtoola Z., et al. Binding and uptake of biodegradable poly-dl-lactide micro- and nanoparticles in intestinal epithelia. Eur J Pharm Sci 6 2 (1998) 153-163
12. Jung T., Kamm W., Breitenbach A., Hungerer K.D., Hundt E., and Kissel T. Tetanus toxoid loaded nanoparticles from sulfobutylated poly(vinyl alcohol)-graft-poly(lactide-co-glycolide): evaluation of antibody response after oral and nasal application in mice. Pharm Res 18 3 (2001) 352-360
13. Cronkhite R.I., and Michael J.G. Sub-compartmentalization of the gastrointestinal (GI) immune system determined with microbeads that differ in release properties. Vaccine 22 17-18 (2004) 2106-2115
14. Bennewitz N.L., and Babensee J.E. The effect of the physical form of poly(lactic-co-glycolic acid) carriers on the humoral immune response to co-delivered antigen. Biomaterials 26 16 (2005) 2991-2999
15. Delgado A., Lavelle E.C., Hartshorne M., and Davis S.S. PLG microparticles stabilised using enteric coating polymers as oral vaccine delivery systems. Vaccine 17 22 (1999) 2927-2938
16. Florence A.T., Hillery A.M., Hussain N., and Jani P.U. Factors affecting the oral uptake and translocation of polystyrene nanoparticles: histological and analytical evidence. J Drug Target 3 1 (1995) 65-70
17. Uto T., Wang X., Sato K., Haraguchi M., Akagi T., Akashi M., et al. Targeting of antigen to dendritic cells with poly(gamma-glutamic acid) nanoparticles induces antigen-specific humoral and cellular immunity. J Immunol 178 5 (2007) 2979-2986
18. Manolova V., Flace A., Bauer M., Schwarz K., Saudan P., and Bachmann M.F. Nanoparticles target distinct dendritic cell populations according to their size. Eur J Immunol 38 5 (2008) 1404-1413
19. Mowat A.M. Dendritic cells and immune responses to orally administered antigens. Vaccine 23 15 (2005) 1797-1799
20. Arbos P., Campanero M.A., Arangoa M.A., Renedo M.J., and Irache J.M. Influence of the surface characteristics of PVM/MA nanoparticles on their bioadhesive properties. J Control Release 89 1 (2003) 19-30
21. Sayin B., Somavarapu S., Li X.W., Thanou M., Sesardic D., Alpar H.O., et al. Mono-N-carboxymethyl chitosan (MCC) and N-trimethyl chitosan (TMC) nanoparticles for non-invasive vaccine delivery. Int J Pharm 363 1-2 (2008) 139-148
22. Arbos P., Arangoa M.A., Campanero M.A., and Irache J.M. Quantification of the bioadhesive properties of protein-coated PVM/MA nanoparticles. Int J Pharm 242 1-2 (2002) 129-136
23. Irache J.M., Huici M., Konecny M., Espuelas S., Campanero M.A., and Arbos P. Bioadhesive properties of Gantrez nanoparticles. Molecules 10 1 (2005) 126-145
24. Gabor F., Bogner E., Weissenboeck A., and Wirth M. The lectin-cell interaction and its implications to intestinal lectin-mediated drug delivery. Adv Drug Deliv Rev 56 4 (2004) 459-480
25. Arbos P., Wirth M., Arangoa M.A., Gabor F., and Irache J.M. Gantrez AN as a new polymer for the preparation of ligand-nanoparticle conjugates. J Control Release 83 3 (2002) 321-330
26. Garinot M., Fievez V., Pourcelle V., Stoffelbach F., des Rieux A., Plapied L., et al. PEGylated PLGA-based nanoparticles targeting M cells for oral vaccination. J Control Release 120 3 (2007) 195-204
27. Gullberg E., Keita A.V., Salim S.Y., Andersson M., Caldwell K.D., Soderholm J.D., et al. Identification of cell adhesion molecules in the human follicle-associated epithelium that improve nanoparticle uptake into the Peyer's patches. J Pharmacol Exp Ther 319 2 (2006) 632-639
28. Brayden D.J., and Baird A.W. Apical membrane receptors on intestinal M cells: potential targets for vaccine delivery. Adv Drug Deliv Rev 56 6 (2004) 721-726
29. Dawson G.F., and Halbert G.W. The in vitro cell association of invasin coated polylactide-co-glycolide nanoparticles. Pharm Res 17 11 (2000) 1420-1425
30. Salman H.H., Gamazo C., Campanero M.A., and Irache J.M. Salmonella-like bioadhesive nanoparticles. J Control Release 106 1-2 (2005) 1-13
31. Russell-Jones G.J., Arthur L., and Walker H. Vitamin B12-mediated transport of nanoparticles across Caco-2 cells. Int J Pharm 179 2 (1999) 247-255
32. Salman H.H., Gamazo C., Agueros M., and Irache J.M. Bioadhesive capacity and immunoadjuvant properties of thiamine-coated nanoparticles. Vaccine 25 48 (2007) 8123-8132
33. Salman H.H., Gamazo C., de Smidt P.C., Russell-Jones G., and Irache J.M. Evaluation of bioadhesive capacity and immunoadjuvant properties of vitamin B(12)-Gantrez nanoparticles. Pharm Res 25 12 (2008) 2859-2868
34. Salman H.H., Gamazo C., Campanero M.A., and Irache J.M. Bioadhesive mannosylated nanoparticles for oral drug delivery. J Nanosci Nanotechnol 6 9-10 (2006) 3203-3209
35. Borges O., Borchard G., Verhoef J.C., de Sousa A., and Junginger H.E. Preparation of coated nanoparticles for a new mucosal vaccine delivery system. Int J Pharm 299 1-2 (2005) 155-166
36. Dalle F., Jouault T., Trinel P.A., Esnault J., Mallet J.M., d'Athis P., et al. Beta-1,2- and alpha-1,2-linked oligomannosides mediate adherence of Candida albicans blastospores to human enterocytes in vitro. Infect Immun 71 12 (2003) 7061-7068
37. Gruden-Movsesijan A., Petrovic M., and Sofronic-Milosavljevic L. Interaction of mannan-binding lectin with Trichinella spiralis glycoproteins, a possible innate immune mechanism. Parasite Immunol 25 11-12 (2003) 545-552
38. Wagner S., Lynch N.J., Walter W., Schwaeble W.J., and Loos M. Differential expression of the murine mannose-binding lectins A and C in lymphoid and nonlymphoid organs and tissues. J Immunol 170 3 (2003) 1462-1465
39. Linehan S.A. The mannose receptor is expressed by subsets of APC in non-lymphoid organs. BMC Immunol 6 1 (2005) 4
40. Keler T., Ramakrishna V., and Fanger M.W. Mannose receptor-targeted vaccines. Expert Opin Biol Ther 4 12 (2004) 1953-1962
41. Engering A.J., Cella M., Fluitsma D.M., Hoefsmit E.C., Lanzavecchia A., and Pieters J. Mannose receptor mediated antigen uptake and presentation in human dendritic cells. Adv Exp Med Biol 417 (1997) 183-187
42. Copland M.J., Baird M.A., Rades T., McKenzie J.L., Becker B., Reck F., et al. Liposomal delivery of antigen to human dendritic cells. Vaccine 21 9-10 (2003) 883-890
43. Jain S.K., Gupta Y., Jain A., Saxena A.R., Khare P., and Jain A. Mannosylated gelatin nanoparticles bearing an anti-HIV drug didanosine for site-specific delivery. Nanomedicine 4 1 (2008) 41-48
44. Hayashi F., Smith K.D., Ozinsky A., Hawn T.R., Yi E.C., Goodlett D.R., et al. The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature 410 6832 (2001) 1099-1103
45. Ramos H.C., Rumbo M., and Sirard J.C. Bacterial flagellins: mediators of pathogenicity and host immune responses in mucosa. Trends Microbiol 12 11 (2004) 509-517
46. Lee S.E., Kim S.Y., Jeong B.C., Kim Y.R., Bae S.J., Ahn O.S., et al. A bacterial flagellin, Vibrio vulnificus FlaB, has a strong mucosal adjuvant activity to induce protective immunity. Infect Immun 74 1 (2006) 694-702
47. Ochoa-Reparaz J., Sesma B., Alvarez M., Jesus Renedo M., Irache J.M., and Gamazo C. Humoral immune response in hens naturally infected with Salmonella Enteritidis against outer membrane proteins and other surface structural antigens. Vet Res 35 3 (2004) 291-298
48. Benson J.R., and Hare P.E. O-phthalaldehyde: fluorogenic detection of primary amines in the picomole range. Comparison with fluorescamine and ninhydrin. Proc Natl Acad Sci USA 72 2 (1975) 619-622
49. Maciel M., Fusaro A.E., Oliveira C.R., Futata E.A., Duarte A.J., and Sato M.N. IgA response in serum and gut secretion in sensitized mice fed with the dust mite Dermatophagoides pteronyssinus extract. Braz J Med Biol Res 37 6 (2004) 817-826
50. Sallusto F., Cella M., Danieli C., and Lanzavecchia A. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J Exp Med 182 2 (1995) 389-400
51. East L., and Isacke C.M. The mannose receptor family. Biochim Biophys Acta 1572 2-3 (2002) 364-386
52. van Kooyk Y. C-type lectins on dendritic cells: key modulators for the induction of immune responses. Biochem Soc Trans 36 Pt 6 (2008) 1478-1481
53. McSorley S.J., Ehst B.D., and Yu Y.T.G.A. Bacterial flagellin is an effective adjuvant for CD4 T cells in vivo. J Immunol 169 (2002) 3914
54. Honko A.N., and Mizel S.B. Effects of flagellin on innate and adaptive immunity. Immunol Res 33 (2005) 83-102
55. Umamaheswari R.B., Jain S., Tripathi P.K., Agrawal G.P., and Jain N.K. Floating-bioadhesive microspheres containing acetohydroxamic acid for clearance of Helicobacter pylori. Drug Deliv 9 4 (2002) 223-231
56. Hattori Y., Kawakami S., Suzuki S., Yamashita F., and Hashida M. Enhancement of immune responses by DNA vaccination through targeted gene delivery using mannosylated cationic liposome formulations following intravenous administration in mice. Biochem Biophys Res Commun 317 4 (2004) 992-999
57. Cui Z., Han S.J., and Huang L. Coating of mannan on LPD particles containing HPV E7 peptide significantly enhances immunity against HPV-positive tumor. Pharm Res 21 6 (2004) 1018-1025
58. Jump R.L., and Levine A.D. Murine Peyer's patches favor development of an IL-10-secreting, regulatory T cell population. J Immunol 168 12 (2002) 6113-6119
59. Jain S., Singh P., Mishra V., and Vyas S.P. Mannosylated niosomes as adjuvant-carrier system for oral genetic immunization against hepatitis B. Immunol Lett 101 1 (2005) 41-49